GOSS.OQ - Gossamer Bio Inc
H.C. Wainwright & Co., LLC
Two-Study NDA Package: A Credible Regulatory Path Could Emerge in Mid-June FDA meeting; 4Q25 Results; Reiterate Buy
公司
GOSS.OQ
日期
2026-03-19
分析师
Patrick R. Trucchio, CFA
页数
8 页
获取研报PDF
将完整研报PDF发送到您的邮箱。
请求PDF
转换为音频
将研报转换为AI生成的音频摘要,随时随地收听。
生成音频
需要登录
请登录后购买研报或生成音频内容。
Two-Study NDA Package: A Credible Regulatory Path Could Emerge in Mid-June FDA meeting; 4Q25 Results; Reiterate Buy - Gossamer Bio Inc (GOSS.OQ) | 研报说 MoneyTalk | 研报说